跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GALVUMET 50/850 vildagliptin 50 mg/metformin hydrochloride 850 mg film coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
GALVUMET 50/850 vildagliptin 50 mg/metformin hydrochloride 850 mg film coated tablet blister pack
Approved
STANDARD
GALVUMET 50/850 vildagliptin 50 mg/metformin hydrochloride 850 mg film coated tablet blister pack
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
da7a69e15e952538
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
da7a69e15e952538
Product Name
GALVUMET 50/850 vildagliptin 50 mg/metformin hydrochloride 850 mg film coated tablet blister pack
Artg Id
161217
Artg Name
GALVUMET 50/850 vildagliptin 50 mg/metformin hydrochloride 850 mg film coated tablet blister pack
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
2010-12-13
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/36b18a7ddd8e5519f615ce9224c4f2be.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/71177335ee76ed37ffad6c78b8d71124.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
da7a69e15e952538
Type
Standard
Back to TGA Approvals